While most fertility centers focus only on what other researchers think are the “best” treatment strategies, we focus instead on improving the outcomes of all infertility patients, both those who receive care from us and those who must receive their care elsewhere.
One of the most important areas of research in reproductive medicine today is the use of PRP or EPF for Ovarian Rejuvenation. PRP is short for Platelet Rich Plasma Therapy and ERP is the abbreviation for Enriched Platelet Factors ( including EnPLAF). These two therapies are similar but do have significant differences. Please see our detailed webpage about Ovarian Rejuvenation for more information.
Over the past two years, the clinical staff at Gen 5 Fertility has published several scientific papers about PRP / EnPLAF and additional papers have been accepted or are being considered for publication at the present time. Below are PDF versions of some of these.
Immediately below is our latest publication, one that provides the logical thinking and some of the prior research that explains how platelet derived growth factors may serve the rejuvenate the ovaries. It’s not an easy ready, but because it provides many of the details behind these procedures, it may be worth the effort.
Wood, S. H., & Sills, E. S. (2020). Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes. Clinical and experimental reproductive medicine, 10.5653/cerm.2019.03405. Advance online publication. https://doi.org/10.5653/cerm.2019.03405
Sills ES, Rickers NS, Peterson JL, Xiang Li, Wood SH. (2020) Regenerative effect of intraovarian injection of activated autologous platelet rich plasma: serum anti-mullerian hormone levels measured among poor-prognosis in vitro fertilization patients. Intl J Regen Med 2020;3(1):1-5
Sills, E. S., & Wood, S. H. (2019). Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Bioscience reports, 39(6), BSR20190805. https://doi.org/10.1042/BSR20190805
Sills, E. S., Li, X., Rickers, N. S., Wood, S. H., & Palermo, G. D. (2019). Metabolic and neurobehavioral response following intraovarian administration of autologous activated platelet rich plasma: First qualitative data. Neuro endocrinology letters, 39(6), 427–433.
Sills, E. S., Rickers, N. S., Li, X., & Palermo, G. D. (2018). First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 34(9), 756–760. https://doi.org/10.1080/09513590.2018.1445219
Sills, E. S., Anderson, R. E., McCaffrey, M., Li, X., Arrach, N., & Wood, S. H. (2016). Gestational surrogacy and the role of routine embryo screening: Current challenges and future directions for preimplantation genetic testing. Birth defects research. Part C, Embryo today : reviews, 108(1), 98–102. https://doi.org/10.1002/bdrc.21112
We will review your medical records, and chat with you to get your thoughts. We will then give you our initial thoughts on the right approach for you. After the consultation, our financial coordination team will follow up based on the tentative treatment plan to navigate you through the financials, as they will guide you to take advantage of your insurance coverage, our discounted global cash packages, or our financing options.
3420 Carmel Mountain Rd Ste 200 San Diego, CA 92121
Copyright © 2020 Gen5Fertility. All Rights Reserved.